Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort

被引：0
|
作者：
Shekhar Sehgal
Manish Khanolkar
机构：
[1] Waikato Hospital,Diabetes and Endocrinology registrar, Department of Endocrinology and Diabetes
[2] Greenlane Clinical Centre,undefined
来源：
Diabetes Therapy | 2015年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：99 / 99
相关论文
共 50 条
  • [41] Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta-analysis
    Yang, Qin
    Zeng, Baoqi
    Hao, Jiayi
    Yang, Qingqing
    Sun, Feng
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3753 - 3763
  • [42] Increase in Body Weight in Type-2-Diabetes-patients after Starting on Insulin Therapy
    Jecht, M.
    DIABETOLOGE, 2014, 10 (06): : 488 - 489
  • [43] Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Katamine, Aki
    Kondo, Yuichiro
    Babazono, Tetsuya
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (11) : 1983 - 1991
  • [44] Insulin intensification with basal plus mealtime insulin or mid-mixture premixed insulin in type 2 diabetes in real-world clinical practice
    Yang, Yi-Sun
    Huang, Chien-Ning
    Kornelius, Edy
    Lo, Shih-Chang
    Wu, Yueh-Chu
    Li, Ching-Lu
    Lin, Yu-Tze
    Hsiao, Hui-Wen
    Chia, Tin-Wen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S94 - S95
  • [45] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin Detemir
    Wu, Jasmanda
    Bailey, Timothy S.
    Bosnyak, Zsolt
    Westerbacka, Jukka
    Gupta, Rishab A.
    Menon, Arjun A.
    Nicholls, Charlie
    Blonde, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417
  • [46] Closed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data
    Toschi, Elena
    Atakov-Castillo, Astrid
    Slyne, Christine
    Munshi, Medha
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 140 - 142
  • [47] The effect of insulin degludec in people with type 2 diabetes in real-world clinical practice in China
    Zhu, D.
    Chang, X.
    Lehrskov, L. L.
    Li, L.
    Nordentoft, M.
    Quan, J.
    Sha, Y.
    Xing, Z.
    Yang, C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [48] Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
    Wu, Yiming
    Zhang, Junqing
    Li, Ang
    DIABETES THERAPY, 2024, 15 (12) : 2515 - 2523
  • [49] Progression of Position of Basal Insulin in the Treatment of Type 2 Diabetes-A Real-World Analysis
    Schapiro, David
    Meeks, Alexandra
    Liu, Dongju
    Gelsey, Felicia
    Juneja, Rattan
    Perez-Nieves, Magaly
    Huang, Ahong
    DIABETES, 2022, 71
  • [50] REAL-WORLD ROLLOUT OF AUTOMATED INSULIN DELIVERY IN TYPE 1 DIABETES PREGNANCY
    Murphy, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A10 - A11
12345